Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans
OPEN BMJ open | 6 Jul 2017
Y Xie, B Bowe, T Li, H Xian, Y Yan and Z Al-Aly
Proton pump inhibitors (PPIs) are widely used, and their use is associated with increased risk of adverse events. However, whether PPI use is associated with excess risk of death is unknown. We aimed to examine the association between PPI use and risk of all-cause mortality.
* Data courtesy of Altmetric.com